As the evidence has accumulated about the clinical importance of low-level resistant variants, attention is being shifted toward the potential incorporation of new sensitive genotyping technology into ...
Data from our group have demonstrated that some, but not all, low-level resistant variants can lead to virologic failure as other active agents in a regimen (with different genetic barriers) may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results